BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Friedrich-Rust M, Klopffleisch T, Nierhoff J, Herrmann E, Vermehren J, Schneider MD, Zeuzem S, Bojunga J. Contrast-Enhanced Ultrasound for the differentiation of benign and malignant focal liver lesions: a meta-analysis. Liver Int. 2013;33:739-755. [PMID: 23432804 DOI: 10.1111/liv.12115] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 7.9] [Reference Citation Analysis]
Number Citing Articles
1 Vidili G, De Sio I, D'Onofrio M, Mirk P, Bertolotto M, Schiavone C; SIUMB experts committee. SIUMB guidelines and recommendations for the correct use of ultrasound in the management of patients with focal liver disease. J Ultrasound 2019;22:41-51. [PMID: 30580390 DOI: 10.1007/s40477-018-0343-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
2 Kim G, Baik SK. Overview and recent trends of systematic reviews and meta-analyses in hepatology. Clin Mol Hepatol. 2014;20:137-150. [PMID: 25032179 DOI: 10.3350/cmh.2014.20.2.137] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
3 Ilunga-mbuyamba E, Lindner D, Avina-cervantes J, Arlt F, Rostro-gonzalez H, Cruz-aceves I, Chalopin C. Fusion of Intraoperative 3D B-mode and Contrast-Enhanced Ultrasound Data for Automatic Identification of Residual Brain Tumors. Applied Sciences 2017;7:415. [DOI: 10.3390/app7040415] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
4 Knieling F, Waldner MJ. Light and sound - emerging imaging techniques for inflammatory bowel disease. World J Gastroenterol 2016; 22(25): 5642-5654 [PMID: 27433080 DOI: 10.3748/wjg.v22.i25.5642] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
5 Schellhaas B, Waldner M, Görtz R, Vitali F, Kielisch C, Pfeifer L, Strobel D, Janka R, Neurath M, Wildner D. Diagnostic accuracy and interobserver variability of Dynamic Vascular Pattern (DVP) in primary liver malignancies – A simple semiquantitative tool for the analysis of contrast enhancement patterns. CH 2017;66:317-31. [DOI: 10.3233/ch-16238] [Cited by in Crossref: 11] [Article Influence: 2.2] [Reference Citation Analysis]
6 Zhu K, Wang W, Luo R, Song D, Wang X, Gao Q, Fan J, Zhou J, Rao S, Wang X. Newly detected liver nodules with a history of colorectal cancer: are they metastatic? Review of 2,632 cases in a single center. Ann Transl Med 2021;9:1079. [PMID: 34422991 DOI: 10.21037/atm-20-8153] [Reference Citation Analysis]
7 Lorentzen T, Nolsoe CP. The Role of US Contrast Agents in US-Guided Biopsy of Focal Liver Lesions: A Pictorial Review. Ultrasound Int Open 2019;5:E11-9. [PMID: 30599041 DOI: 10.1055/a-0770-4237] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Grieser C, Steffen IG, Kramme IB, Bläker H, Kilic E, Perez Fernandez CM, Seehofer D, Schott E, Hamm B, Denecke T. Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. Eur Radiol 2014;24:1339-48. [PMID: 24658870 DOI: 10.1007/s00330-014-3144-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
9 Ta CN, Kono Y, Eghtedari M, Oh YT, Robbin ML, Barr RG, Kummel AC, Mattrey RF. Focal Liver Lesions: Computer-aided Diagnosis by Using Contrast-enhanced US Cine Recordings. Radiology. 2018;286:1062-1071. [PMID: 29072980 DOI: 10.1148/radiol.2017170365] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
10 Schellhaas B, Görtz RS, Pfeifer L, Kielisch C, Neurath MF, Strobel D. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS. Eur J Gastroenterol Hepatol 2017;29:1036-44. [PMID: 28562394 DOI: 10.1097/MEG.0000000000000916] [Cited by in Crossref: 31] [Cited by in F6Publishing: 6] [Article Influence: 7.8] [Reference Citation Analysis]
11 Ferraioli G, Meloni MF. Contrast-enhanced ultrasonography of the liver using SonoVue. Ultrasonography. 2018;37:25-35. [PMID: 28830058 DOI: 10.14366/usg.17037] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
12 Görtz RS, Schellhaas B. Sonographie bei Leberzirrhose: von der TIPSS-Funktionsprüfung zur LI-RADS®-Klassifikation. Gastroenterologe 2018;13:292-7. [DOI: 10.1007/s11377-018-0270-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Sawatzki M, Güller U, Güsewell S, Husarik DB, Semela D, Brand S. Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases. J Hepatol 2021;74:419-27. [PMID: 33065168 DOI: 10.1016/j.jhep.2020.09.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Hu Z, Yang B, Li T, Li J. Thyroid Cancer Detection by Ultrasound Molecular Imaging with SHP2-Targeted Perfluorocarbon Nanoparticles. Contrast Media Mol Imaging 2018;2018:8710862. [PMID: 29706844 DOI: 10.1155/2018/8710862] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Strobel D. Using contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma - what we have and have not achieved. Ultraschall Med 2021;42:120-4. [PMID: 33845488 DOI: 10.1055/a-1347-1388] [Reference Citation Analysis]
16 Muskiet MHA, Emanuel AL, Smits MM, Tonneijck L, Meijer RI, Joles JA, Serné EH, van Raalte DH. Assessment of real‐time and quantitative changes in renal hemodynamics in healthy overweight males: Contrast‐enhanced ultrasonography vs para‐aminohippuric acid clearance. Microcirculation 2019;26. [DOI: 10.1111/micc.12580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Carrara S, Repici A. Kupffer-phase EUS: the contrast agent that magnifies liver metastasis. Gastrointest Endosc 2021;93:442-3. [PMID: 33478665 DOI: 10.1016/j.gie.2020.09.035] [Reference Citation Analysis]
18 Vande Lune P, Abdel Aal AK, Klimkowski S, Zarzour JG, Gunn AJ. Hepatocellular Carcinoma: Diagnosis, Treatment Algorithms, and Imaging Appearance after Transarterial Chemoembolization. J Clin Transl Hepatol 2018;6:175-88. [PMID: 29951363 DOI: 10.14218/JCTH.2017.00045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
19 Dietrich CF, Potthoff A, Helmberger T, Ignee A, Willmann JK; on behalf of the CEUS LI-RADS Working Group. Standardisierte Befundung und Dokumentation der Kontrastmittelsonografie der Leber (CEUS LI-RADS). Z Gastroenterol 2018;56:499-506. [DOI: 10.1055/s-0043-124874] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
20 Salvatore V, Gianstefani A, Negrini G, Allegretti G, Galassi M, Piscaglia F. Imaging Diagnosis of Hepatocellular Carcinoma: Recent Advances of Contrast-Enhanced Ultrasonography with SonoVue®. Liver Cancer 2016;5:55-66. [PMID: 29234627 DOI: 10.1159/000367748] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
21 Barr RG. How to Develop a Contrast-Enhanced Ultrasound Program. J Ultrasound Med 2017;36:1225-40. [PMID: 28151552 DOI: 10.7863/ultra.16.09045] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
22 Li W, Lv XZ, Zheng X, Ruan SM, Hu HT, Chen LD, Huang Y, Li X, Zhang CQ, Xie XY, Kuang M, Lu MD, Zhuang BW, Wang W. Machine Learning-Based Ultrasomics Improves the Diagnostic Performance in Differentiating Focal Nodular Hyperplasia and Atypical Hepatocellular Carcinoma. Front Oncol 2021;11:544979. [PMID: 33842303 DOI: 10.3389/fonc.2021.544979] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 . UEG Week 2018 Poster Presentations. United European Gastroenterol j 2018;6. [DOI: 10.1177/2050640618792819] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
24 Borro P, Testino G. Contrast-enhanced ultrasound for focal liver lesions. Is it necessary an hepatologist expert in ultrasound techniques in the third millennium? Liver Int 2013;33:1609-10. [PMID: 23998437 DOI: 10.1111/liv.12289] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Moga TV, David C, Popescu A, Lupusoru R, Heredea D, Ghiuchici AM, Foncea C, Burdan A, Sirli R, Danilă M, Ratiu I, Bizerea-Moga T, Sporea I. Multiparametric Ultrasound Approach Using a Tree-Based Decision Classifier for Inconclusive Focal Liver Lesions Evaluated by Contrast Enhanced Ultrasound. J Pers Med 2021;11:1388. [PMID: 34945860 DOI: 10.3390/jpm11121388] [Reference Citation Analysis]
26 Nolsøe CP, Lorentzen T. International guidelines for contrast-enhanced ultrasonography: ultrasound imaging in the new millennium. Ultrasonography 2016;35:89-103. [PMID: 26867761 DOI: 10.14366/usg.15057] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
27 Ronot M, Di Renzo S, Gregoli B, Duran R, Castera L, Van Beers BE, Vilgrain V. Characterization of fortuitously discovered focal liver lesions: additional information provided by shearwave elastography. Eur Radiol. 2015;25:346-358. [PMID: 25231131 DOI: 10.1007/s00330-014-3370-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
28 Kondo T, Maruyama H, Kiyono S, Sekimoto T, Shimada T, Takahashi M, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Chiba T, Kanai F, Yokosuka O. Intensity-Based Assessment of Microbubble-Enhanced Ultrasonography: Phase-Related Diagnostic Ability for Cellular Differentiation of Hepatocellular Carcinoma. Ultrasound in Medicine & Biology 2015;41:3079-87. [DOI: 10.1016/j.ultrasmedbio.2015.07.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
29 Dietrich CF, Nolsøe CP, Barr RG, Berzigotti A, Burns PN, Cantisani V, Chammas MC, Chaubal N, Choi BI, Clevert DA, Cui X, Dong Y, D'Onofrio M, Fowlkes JB, Gilja OH, Huang P, Ignee A, Jenssen C, Kono Y, Kudo M, Lassau N, Lee WJ, Lee JY, Liang P, Lim A, Lyshchik A, Meloni MF, Correas JM, Minami Y, Moriyasu F, Nicolau C, Piscaglia F, Saftoiu A, Sidhu PS, Sporea I, Torzilli G, Xie X, Zheng R. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver - Update 2020 - WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultraschall Med 2020;41:562-85. [PMID: 32707595 DOI: 10.1055/a-1177-0530] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
30 Pang EHT, Chan A, Ho SG, Harris AC. Contrast-Enhanced Ultrasound of the Liver: Optimizing Technique and Clinical Applications. AJR Am J Roentgenol. 2018;210:320-332. [PMID: 29220210 DOI: 10.2214/ajr.17.17843] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
31 Hsiao CY, Chen PD, Huang KW. A Prospective Assessment of the Diagnostic Value of Contrast-Enhanced Ultrasound, Dynamic Computed Tomography and Magnetic Resonance Imaging for Patients with Small Liver Tumors. J Clin Med 2019;8:E1353. [PMID: 31480576 DOI: 10.3390/jcm8091353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
32 Li F, Bai M, Wu Y, He Y, Gu J, Xing J, Du L. Comparative Diagnostic Performance of Contrast-Enhanced ultrasound versus Baseline Ultrasound for Renal Pelvis Lesions. Ultrasound Med Biol 2015;41:3109-19. [PMID: 26391561 DOI: 10.1016/j.ultrasmedbio.2015.07.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
33 Testino G, Leone S, Borro P. Alcohol and hepatocellular carcinoma: A review and a point of view. World J Gastroenterol 2014; 20(43): 15943-15954 [PMID: 25473148 DOI: 10.3748/wjg.v20.i43.15943] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 55] [Article Influence: 7.9] [Reference Citation Analysis]
34 Gupta M, Gabriel H, Miller FH. Role of Imaging in Surveillance and Diagnosis of Hepatocellular Carcinoma. Gastroenterology Clinics of North America 2018;47:585-602. [DOI: 10.1016/j.gtc.2018.04.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
35 Wildner D, Schellhaas B, Strack D, Goertz RS, Pfeifer L, Fiessler C, Neurath MF, Strobel D. Differentiation of malignant liver tumors by software-based perfusion quantification with dynamic contrast-enhanced ultrasound (DCEUS). CH 2019;71:39-51. [DOI: 10.3233/ch-180378] [Cited by in Crossref: 29] [Cited by in F6Publishing: 5] [Article Influence: 9.7] [Reference Citation Analysis]
36 Tana C, Dietrich CF, Schiavone C. Hepatosplenic sarcoidosis: contrast-enhanced ultrasound findings and implications for clinical practice. Biomed Res Int. 2014;2014:926203. [PMID: 25215299 DOI: 10.1155/2014/926203] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
37 Wu JP, Shu R, Zhao YZ, Ma GL, Xue W, He QJ, Hao MN, Liu Y. Comparison of contrast-enhanced ultrasonography with virtual touch tissue quantification in the evaluation of focal liver lesions. J Clin Ultrasound 2016;44:347-53. [PMID: 26890486 DOI: 10.1002/jcu.22335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
38 Dietrich CF, Nolsøe CP, Barr RG, Berzigotti A, Burns PN, Cantisani V, Chammas MC, Chaubal N, Choi BI, Clevert DA, Cui X, Dong Y, D'Onofrio M, Fowlkes JB, Gilja OH, Huang P, Ignee A, Jenssen C, Kono Y, Kudo M, Lassau N, Lee WJ, Lee JY, Liang P, Lim A, Lyshchik A, Meloni MF, Correas JM, Minami Y, Moriyasu F, Nicolau C, Piscaglia F, Saftoiu A, Sidhu PS, Sporea I, Torzilli G, Xie X, Zheng R. Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultrasound Med Biol 2020;46:2579-604. [PMID: 32713788 DOI: 10.1016/j.ultrasmedbio.2020.04.030] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 19.5] [Reference Citation Analysis]
39 Platz Batista da Silva N, Schauer M, Hornung M, Lang S, Beyer LP, Wiesinger I, Stroszczynski C, Jung EM. Intrasurgical dignity assessment of hepatic tumors using semi-quantitative strain elastography and contrast-enhanced ultrasound for optimisation of liver tumor surgery. Clin Hemorheol Microcirc 2016;64:735-45. [PMID: 27767982 DOI: 10.3233/CH-168029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
40 Ma X, Zhang B, Ling W, Liu R, Jia H, Zhu F, Wang M, Liu H, Huang J, Liu L. Contrast-enhanced sonography for the identification of benign and malignant thyroid nodules: Systematic review and meta-analysis. J Clin Ultrasound 2016;44:199-209. [PMID: 26402325 DOI: 10.1002/jcu.22311] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
41 Taimr P, Bröker MEE, Dwarkasing RS, Hansen BE, de Knegt RJ, De Man RA, IJzermans JNM. A Model-Based Prediction of the Probability of Hepatocellular Adenoma and Focal Nodular Hyperplasia Based on Characteristics on Contrast-Enhanced Ultrasound. Ultrasound Med Biol 2017;43:2144-50. [PMID: 28743375 DOI: 10.1016/j.ultrasmedbio.2017.05.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
42 Grgurevic I, Tjesic Drinkovic I, Pinzani M. Multiparametric ultrasound in liver diseases: an overview for the practising clinician. Postgrad Med J 2019;95:425-32. [PMID: 30665903 DOI: 10.1136/postgradmedj-2018-136111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
43 Fang C, Bernardo S, Sellars ME, Deganello A, Sidhu PS. Contrast-enhanced ultrasound in the diagnosis of pediatric focal nodular hyperplasia and hepatic adenoma: interobserver reliability. Pediatr Radiol 2019;49:82-90. [DOI: 10.1007/s00247-018-4250-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
44 Chung YE, Kim KW. Contrast-enhanced ultrasonography: advance and current status in abdominal imaging. Ultrasonography. 2015;34:3-18. [PMID: 25342120 DOI: 10.14366/usg.14034] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 10.1] [Reference Citation Analysis]
45 Nolsøe CP, Nolsøe AB, Klubien J, Pommergaard H, Rosenberg J, Meloni MF, Lorentzen T. Use of Ultrasound Contrast Agents in Relation to Percutaneous Interventional Procedures: A Systematic Review and Pictorial Essay: Contrast-Enhanced Ultrasound-Guided Percutaneous Interventions. J Ultrasound Med 2018;37:1305-24. [DOI: 10.1002/jum.14498] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
46 Lv K, Zhai H, Jiang Y, Liang P, Xu HX, Du L, Chou YH, Xie X, Luo Y, Lee YJ, Lee JY, Hu B, Luo B, Wang Y, Luan Y, Kalli C, Chen K, Wang W, Liang JD. Prospective assessment of diagnostic efficacy and safety of SonazoidTM and SonoVue® ultrasound contrast agents in patients with focal liver lesions. Abdom Radiol (NY) 2021;46:4647-59. [PMID: 34136936 DOI: 10.1007/s00261-021-03010-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
47 Lupsor-Platon M, Serban T, Silion AI, Tirpe GR, Tirpe A, Florea M. Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease. Cancers (Basel) 2021;13:790. [PMID: 33672827 DOI: 10.3390/cancers13040790] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
48 Liu YH, Fan ZH, Yin SS, Yan K, Sun LQ, Jiang BB. Diagnostic value of color parametric imaging and contrast-enhanced ultrasound in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma. J Clin Ultrasound 2022. [PMID: 35084048 DOI: 10.1002/jcu.23138] [Reference Citation Analysis]
49 Chammas MC, Bordini AL. Contrast-enhanced ultrasonography for the evaluation of malignant focal liver lesions. Ultrasonography 2022;41:4-24. [PMID: 34724777 DOI: 10.14366/usg.21001] [Reference Citation Analysis]
50 Barr RG, Huang P, Luo Y, Xie X, Zheng R, Yan K, Jing X, Luo Y, Xu H, Fei X, Lee JM. Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid. Abdom Radiol (NY) 2020;45:3779-88. [PMID: 32424608 DOI: 10.1007/s00261-020-02573-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
51 Hasab Allah M, Salama RM, Marie MS, Mandur AA, Omar H. Utility of point shear wave elastography in characterisation of focal liver lesions. Expert Rev Gastroenterol Hepatol. 2018;12:201-207. [PMID: 29219625 DOI: 10.1080/17474124.2018.1415144] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
52 Negrão de Figueiredo G, Mueller-peltzer K, Schwarze V, Marschner C, Zhang L, Rübenthaler J, Siepmann T, Illigens B, Clevert D. Long-term study analysis of contrast-enhanced ultrasound in the diagnosis of focal nodular hyperplasia. CH 2020;74:441-52. [DOI: 10.3233/ch-190710] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Tamura M, Nakamura K, Osuga T, Shimbo G, Sasaki N, Morishita K, Ohta H, Takiguchi M. Findings of contrast-enhanced ultrasonography with Sonazoid for cholangiocellular adenoma in three dogs. J Vet Med Sci 2019;81:1104-8. [PMID: 31243194 DOI: 10.1292/jvms.19-0116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Sandulescu LD, Urhut CM, Sandulescu SM, Ciurea AM, Cazacu SM, Iordache S. One stop shop approach for the diagnosis of liver hemangioma. World J Hepatol 2021; 13(12): 1892-1908 [DOI: 10.4254/wjh.v13.i12.1892] [Reference Citation Analysis]
55 Barr RG. Contrast enhanced ultrasound for focal liver lesions: how accurate is it? Abdom Radiol (NY) 2018;43:1128-33. [PMID: 28718042 DOI: 10.1007/s00261-017-1257-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
56 Piscaglia F, Sansone V, Tovoli F. Contrast-enhanced ultrasound of the liver in colorectal cancer: A useful tool in the right patient. J Hepatol 2021;74:272-3. [PMID: 33309113 DOI: 10.1016/j.jhep.2020.11.044] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Zheng W, Li Q, Zou XB, Wang JW, Han F, Li F, Huang LS, Li AH, Zhou JH. Evaluation of Contrast-enhanced US LI-RADS version 2017: Application on 2020 Liver Nodules in Patients with Hepatitis B Infection. Radiology. 2020;294:299-307. [PMID: 31769742 DOI: 10.1148/radiol.2019190878] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
58 Wilson SR, Burns PN, Kono Y. Contrast-Enhanced Ultrasound of Focal Liver Masses: A Success Story. Ultrasound Med Biol 2020;46:1059-70. [PMID: 32059917 DOI: 10.1016/j.ultrasmedbio.2019.12.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
59 Hocke M, Ignee A, Dietrich C. Role of contrast-enhanced endoscopic ultrasound in lymph nodes. Endosc Ultrasound. 2017;6:4-11. [PMID: 28218194 DOI: 10.4103/2303-9027.190929] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
60 Whitty J, Filby A, Smith AB, Carr LM. CONSUMER PREFERENCES FOR SCANNING MODALITY TO DIAGNOSE FOCAL LIVER LESIONS. Int J Technol Assess Health Care 2015;31:27-35. [PMID: 26096701 DOI: 10.1017/S0266462315000239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
61 Semaan S, Makkar J, Lewis S, Chatterji M, Kim E, Taouli B. Imaging of Hepatocellular Carcinoma Response After 90 Y Radioembolization. American Journal of Roentgenology 2017;209:W263-76. [DOI: 10.2214/ajr.17.17993] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 3.6] [Reference Citation Analysis]
62 Safai Zadeh E, Baumgarten MA, Dietrich CF, Görg C, Neesse A, Trenker C, Alhyari A. Frequency of synchronous malignant liver lesions initially detected by ultrasound in patients with newly diagnosed underlying non-hematologic malignant disease: a retrospective study in 434 patients. Z Gastroenterol 2021. [PMID: 34670295 DOI: 10.1055/a-1649-8857] [Reference Citation Analysis]
63 Schellhaas B, Hammon M, Strobel D, Pfeifer L, Kielisch C, Goertz RS, Cavallaro A, Janka R, Neurath MF, Uder M, Seuss H. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.Eur Radiol. 2018;28:4254-4264. [PMID: 29675659 DOI: 10.1007/s00330-018-5379-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
64 Ling W, Wang M, Ma X, Qiu T, Li J, Lu Q, Luo Y. The preliminary application of liver imaging reporting and data system (LI-RADS) with contrast-enhanced ultrasound (CEUS) on small hepatic nodules (≤ 2cm). J Cancer 2018;9:2946-52. [PMID: 30123363 DOI: 10.7150/jca.25539] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]